PNC Financial Services Group’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25K | Sell |
110
-10
| -8% | -$204 | ﹤0.01% | 4379 |
|
|
2025
Q1 | $2.4K | Buy |
+120
| New | +$2.4K | ﹤0.01% | 4293 |
|
|
2024
Q2 | – | Sell |
-38
| Closed | -$842 | – | 4783 |
|
|
2024
Q1 | $842 | Hold |
38
| – | – | ﹤0.01% | 4403 |
|
|
2023
Q4 | $820 | Sell |
38
-2,226
| -98% | -$48K | ﹤0.01% | 4345 |
|
|
2023
Q3 | $38.2K | Sell |
2,264
-337
| -13% | -$5.69K | ﹤0.01% | 3093 |
|
|
2023
Q2 | $35.7K | Buy |
2,601
+5
| +0.2% | +$69 | ﹤0.01% | 3250 |
|
|
2023
Q1 | $59K | Sell |
2,596
-154
| -6% | -$3.5K | ﹤0.01% | 2887 |
|
|
2022
Q4 | $64.7K | Sell |
2,750
-985
| -26% | -$23.2K | ﹤0.01% | 2823 |
|
|
2022
Q3 | $97K | Buy |
3,735
+41
| +1% | +$1.07K | ﹤0.01% | 2549 |
|
|
2022
Q2 | $81K | Sell |
3,694
-51
| -1% | -$1.12K | ﹤0.01% | 2704 |
|
|
2022
Q1 | $168K | Buy |
3,745
+1,290
| +53% | +$57.9K | ﹤0.01% | 2380 |
|
|
2021
Q4 | $105K | Buy |
2,455
+960
| +64% | +$41.1K | ﹤0.01% | 2651 |
|
|
2021
Q3 | $99K | Buy |
1,495
+147
| +11% | +$9.73K | ﹤0.01% | 2657 |
|
|
2021
Q2 | $99K | Sell |
1,348
-53
| -4% | -$3.89K | ﹤0.01% | 2664 |
|
|
2021
Q1 | $96K | Buy |
1,401
+51
| +4% | +$3.5K | ﹤0.01% | 2597 |
|
|
2020
Q4 | $91K | Buy |
+1,350
| New | +$91K | ﹤0.01% | 2549 |
|